Skip to content

Recovery and Analgesia After Surgery for Gynecological Cancer

Will Intrathecal Analgesia Contribute to a Faster Recovery Compared With Epidural Analgesia After Open Surgery for Gynecological Cancer. An Open Controlled Randomized Study.

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02026687
Acronym
Speed
Enrollment
80
Registered
2014-01-03
Start date
2014-03-31
Completion date
2016-05-31
Last updated
2019-09-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gynecological Cancer

Brief summary

The purpose of the study is to compare epidural analgesia and intrathecal analgesia for explorative laparotomy through a middle-line incision for gynecological cancer in a fast track program to se if there is any difference in recovery. Length of stay is analyzed together with self-rate quality of life.

Interventions

DRUGEpidural

Sponsors

Lena Nilsson
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

* Women with gynecological cancer (suspected or verified) planned for explorative laparotomy through a middle-line incision with a curative purpose. * WHO performance status \< 2. * American Society of Anesthesiologists class 1-2. * Women that understand and can express themselves in Swedish. * Women that after verbal and written information accept participation in the study and have signed an informed consent.

Exclusion criteria

* Women where surgery is expected to include part/s, other than the abdominal surgery, where intrathecal or epidural analgesia is not expected to be effective * Women with contra indications for intrathecal or epidural anesthesia. * Women who are physically disabled and therefore nor expected to be mobilized on the day after surgery in the same way as non-disabled. * Women with a mental retardation that makes it impossible to fill in the relevant questionnaires or makes it impossible to understand the meaning of participation, or if it is ethically doubtful to include the woman. * Women with psychiatric or mental disorder that according to the responsible physician makes it unsuitable to participate in the study .

Design outcomes

Primary

MeasureTime frameDescription
Length of StayParticipants will be followed for the duration of hospital stay, an expected average of 4 daysFrom day of surgery (Day 0) until discharge after surgery

Secondary

MeasureTime frameDescription
Change in Quality of LifePreoperatively and until 6 weeks after surgeryThe questionnaire Short Form with 36 questions SF-36 will be used preoperatively and at 6 weeks after surgery. The SF-36 consists of eight scaled subscores (vitality, physical functioning, bodily pain, general health perceptions, physical role functioning, emotional role functioning, social role functioning, mental Health) and two Component summary scores (physical Component summary scoer, mental component summary score). A score of zero is equivalent to maximum disability and a score of 100 is equivalent to no disability.

Other

MeasureTime frameDescription
Change in PainDay of surgery (day 0) until 6 weeks after surgeryPain at rest will be assessed using a numeric rating scale from 0 (no pain) to 10 (worst imaginable pain). Pain is documented on the day of surgery (day 0), 3 times daily postoperative day 1, 2, 3, 4, 5, 6, 7, 14, 21, 28, 35 and 42. Scale: NRS Minimum value:0 Maximum value: 10. Higher scores indicate worse outcome.

Countries

Sweden

Participant flow

Participants by arm

ArmCount
Epidural Analgesia
The epidural anesthesia is applied at a low thoracic level, primarily Th10-Th11. A bolus dose of fentanyl together with a continuous infusion of bupivacain 2.5 mg/ml, fentanyl 1.8 µg/ml and epinephrine 2.5 µg/ml is used during surgery. Infusion rate is chosen by the attending anesthetist. Postoperatively the epidural anesthesia is continued until the morning of the third postoperative day using bupivacain 1 mg/ml, fentanyl 2 µg/ml and epinephrine 2µg/ml. Infusion rate is set by the responsible physician, maximum rate is 10 ml/hour. Epidural
40
Intrathecal Analgesia
The patient is given one intrathecal dose of plain bupivacaine (Marcain® spinal) 5 mg/ml, 15 mg together with morphine (Morphine Special®) 0,4 mg/ml, 0.2 mg and clonidine (Catapresan®) 150 µg/ml, 75 µg. The intrathecal mixture is given through a lumbal puncture at level L2/3, L3/4 or L4/5 before the induction of general anesthesia. Intrathecal
40
Total80

Baseline characteristics

CharacteristicIntrathecal AnalgesiaTotalEpidural Analgesia
Age, Continuous58.5 years
STANDARD_DEVIATION 8.5
58.7 years
STANDARD_DEVIATION 8.9
59.0 years
STANDARD_DEVIATION 14.5
Race and Ethnicity Not Collected0 Participants
Region of Enrollment
Sweden
40 participants80 participants40 participants
Sex: Female, Male
Female
40 Participants80 Participants40 Participants
Sex: Female, Male
Male
0 Participants0 Participants0 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
— / —— / —
other
Total, other adverse events
17 / 4014 / 40
serious
Total, serious adverse events
2 / 407 / 40

Outcome results

Primary

Length of Stay

From day of surgery (Day 0) until discharge after surgery

Time frame: Participants will be followed for the duration of hospital stay, an expected average of 4 days

ArmMeasureValue (MEDIAN)
EpiduralLength of Stay4.3 days
SpinalLength of Stay3.3 days
Secondary

Change in Quality of Life

The questionnaire Short Form with 36 questions SF-36 will be used preoperatively and at 6 weeks after surgery. The SF-36 consists of eight scaled subscores (vitality, physical functioning, bodily pain, general health perceptions, physical role functioning, emotional role functioning, social role functioning, mental Health) and two Component summary scores (physical Component summary scoer, mental component summary score). A score of zero is equivalent to maximum disability and a score of 100 is equivalent to no disability.

Time frame: Preoperatively and until 6 weeks after surgery

ArmMeasureGroupValue (MEDIAN)
EpiduralChange in Quality of LifeSF-36 Physical component summary score baseline44 units on a scale
EpiduralChange in Quality of LifeSF-36 Physical component summary score day 4239 units on a scale
EpiduralChange in Quality of LifeSF-36 mental component summary score baseline46 units on a scale
EpiduralChange in Quality of LifeSF-36 mental component summary score day 4249 units on a scale
SpinalChange in Quality of LifeSF-36 mental component summary score day 4251 units on a scale
SpinalChange in Quality of LifeSF-36 Physical component summary score baseline45 units on a scale
SpinalChange in Quality of LifeSF-36 mental component summary score baseline46 units on a scale
SpinalChange in Quality of LifeSF-36 Physical component summary score day 4238 units on a scale
Other Pre-specified

Change in Pain

Pain at rest will be assessed using a numeric rating scale from 0 (no pain) to 10 (worst imaginable pain). Pain is documented on the day of surgery (day 0), 3 times daily postoperative day 1, 2, 3, 4, 5, 6, 7, 14, 21, 28, 35 and 42. Scale: NRS Minimum value:0 Maximum value: 10. Higher scores indicate worse outcome.

Time frame: Day of surgery (day 0) until 6 weeks after surgery

ArmMeasureGroupValue (MEAN)
EpiduralChange in PainPain at rest Day 21.5 units on a scale
EpiduralChange in PainPain at rest Day 71.1 units on a scale
EpiduralChange in PainPain at rest Day 41.4 units on a scale
EpiduralChange in PainPain at rest Day 140.8 units on a scale
EpiduralChange in PainPain at rest Day 11.6 units on a scale
EpiduralChange in PainPain at rest Day 210.5 units on a scale
EpiduralChange in PainPain at rest Day 51.1 units on a scale
EpiduralChange in PainPain at rest Day 280.2 units on a scale
EpiduralChange in PainPain at rest Day 32.9 units on a scale
EpiduralChange in PainPain at rest Day 350.3 units on a scale
EpiduralChange in PainPain at rest Day 61.0 units on a scale
EpiduralChange in PainPain at rest Day 420.5 units on a scale
EpiduralChange in PainPain at rest Day 01.5 units on a scale
SpinalChange in PainPain at rest Day 420.1 units on a scale
SpinalChange in PainPain at rest Day 02.7 units on a scale
SpinalChange in PainPain at rest Day 13.2 units on a scale
SpinalChange in PainPain at rest Day 22.1 units on a scale
SpinalChange in PainPain at rest Day 31.4 units on a scale
SpinalChange in PainPain at rest Day 41.6 units on a scale
SpinalChange in PainPain at rest Day 51.2 units on a scale
SpinalChange in PainPain at rest Day 61.1 units on a scale
SpinalChange in PainPain at rest Day 71.0 units on a scale
SpinalChange in PainPain at rest Day 140.7 units on a scale
SpinalChange in PainPain at rest Day 210.3 units on a scale
SpinalChange in PainPain at rest Day 280.2 units on a scale
SpinalChange in PainPain at rest Day 350.3 units on a scale

Source: ClinicalTrials.gov · Data processed: Feb 21, 2026